ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.600
-0.170 (-9.60%)
At close: Mar 27, 2026, 4:00 PM EDT
1.698
+0.098 (6.12%)
After-hours: Mar 27, 2026, 7:57 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $483.07 million as of March 27, 2026. Its market cap has increased by 73.76% in one year.
Market Cap
483.07M
Enterprise Value
217.08M
1-Year Change
73.76%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $483.07M, an increase of 86.66%. That is a compound annual growth rate of 14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 483.10M | -28.31% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 237.97M |
| Voyager Therapeutics | 236.01M |
| C4 Therapeutics | 235.16M |
| Cellectis | 235.00M |
| Silence Therapeutics | 232.86M |
| Cybin | 226.16M |
| Camp4 Therapeutics | 223.77M |
| Inhibikase Therapeutics | 221.81M |